Solid state characterization of chloramphenicol palmitate. Raman spectroscopy applied to pharmaceutical polymorphs

被引:30
作者
Gamberini, MC
Baraldi, C
Tinti, A
Rustichelli, C
Ferioli, V
Gamberini, G
机构
[1] Univ Modena, Dept Pharmaceut Sci, Inst Pharm, I-41100 Modena, Italy
[2] Univ Bologna, Dept Biochem, I-40126 Bologna, Italy
关键词
chloramphenicol palmitate polymorphism; Raman spectroscopy (FT-Raman; Hot-stage Raman microscopy); Fourier-transform infrared spectroscopy (FT-IR); differential scanning calorimetry (DSC); X-ray powder diffraction (XRPD); solid state properties;
D O I
10.1016/j.molstruc.2005.10.012
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
A pharmaceutical active compound, chloramphenicol palmitate, appears in three polymorphic forms, that can be observed at room temperature. The stable form A (biologically inactive modification), the meta-stable form B (active modification) and unstable form C were found to have distinct Raman spectra, with bands attributable to the different polymorphs. The use of hot-stage Raman microscopy (the direct coupling of Raman microscopy and hot-stage) is demonstrated for the drug substance chloramphenicol palmitate form C. All modifications of form C were produced and identified by hot-stage Raman microscopy. A close correlation of thermal and spectroscopic information was achieved by this combination of techniques. As reported in several pharmacopoeias, the content of form A should be less than 10%; therefore, a mixture of 10% (w/w) A in B was prepared, and the presence of the characteristic bands of form A after subtraction of the pure B was revealed. Moreover, mixtures between 2 and 12% (w/w) A in B were investigated and the intensity ratio (as peak area) I413-435/I1035-1158 as a function of A percentage has been demonstrated to show a linear trend. Other methods for the characterization of polymorphs were used: Fourier transform infrared spectroscopy (FT-IR), Diffuse reflectance infrared Fourier transform spectroscopy (DRIFT), Differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD). (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:216 / 224
页数:9
相关论文
共 12 条
[1]   EFFECT OF POLYMORPHISM ON ABSORPTION OF CHLORAMPHENICOL FROM CHLORAMPHENICOL PALMITATE [J].
AGUIAR, AJ ;
KRC, J ;
KINKEL, AW ;
SAMYN, JC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1967, 56 (07) :847-+
[2]   Qualitative and quantitative study of polymorphic forms in drug formulations by near infrared FT-Raman spectroscopy [J].
Auer, ME ;
Griesser, UJ ;
Sawatzki, J .
JOURNAL OF MOLECULAR STRUCTURE, 2003, 661 :307-317
[3]  
BORKA L, 1968, ACTA PHARM SUEC, V5, P271
[4]  
BORKA L, 1970, ACTA PHARM SUEC, V7, P1
[5]   Spectral methods for the characterization of polymorphs and solvates [J].
Brittain, HG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (04) :405-412
[6]  
FERIOLI V, 1974, IL FARMACO ED PR, V29, P309
[7]   Utilization of Fourier transform Raman spectroscopy for the study of pharmaceutical crystal forms [J].
Findlay, WP ;
Bugay, DE .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 16 (06) :921-930
[8]   Applications of Raman spectroscopy to pharmacy [J].
Fini, G .
JOURNAL OF RAMAN SPECTROSCOPY, 2004, 35 (05) :335-337
[9]  
KANENIWA N, 1985, CHEM PHARM BULL, V33, P1660
[10]   Quantitative FT-Raman analysis of two crystal forms of a pharmaceutical compound [J].
Langkilde, FW ;
Sjoblom, J ;
TekenbergsHjelte, L ;
Mrak, J .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1997, 15 (06) :687-696